Literature DB >> 25007061

Depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry.

Amanda Clacy1, Rachael Sharman, Jim McGill.   

Abstract

OBJECTIVE: Increasing concurrent phenylalanine to "off-diet" levels in adults with phenylketonuria (PKU) has been shown to lead to mood disturbances. However, the impact of controlled phenylalanine exposure across the developmental life span and mood stability remains questionable. The aim of this study was to investigate correlations between lifetime and concurrent phenylalanine (Phe) and tyrosine (Tyr) with levels of depression, anxiety, and stress in young adults maintaining a continuously treated diet for PKU.
METHOD: Eight young adults (6 females, 2 males) aged 15 to 25 years (mean = 19.37, SD = 3.62) recruited through the Royal Children's Hospital Brisbane, with early and continuously treated PKU completed the Depression Anxiety Stress Scale, which was correlated with lifetime and concurrent measures of Phe, Tyr, and Phe-Tyr ratios.
RESULTS: There was a strong significant correlation between lifetime Phe and levels of anxiety and stress (p < .01). Greater Phe-to-Tyr blood ratios were indicative of increased depression and anxiety levels (p < .01).
CONCLUSIONS: An interaction between biochemical regulation and depression, anxiety, and stress levels was present in young adults with continuously treated PKU who were actively attempting to maintain dietary control. Strong associations were present with lifetime levels, suggesting a developmental impact of PKU-related biochemical exposure and the emergence of mood disturbances.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007061     DOI: 10.1097/DBP.0000000000000072

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  11 in total

1.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

2.  Improved Measurement of Brain Phenylalanine and Tyrosine Related to Neuropsychological Functioning in Phenylketonuria.

Authors:  Susan E Waisbren; Sanjay P Prabhu; Patricia Greenstein; Carter Petty; Donald Schomer; Vera Anastasoaie; Kalin Charette; Daniel Rodriguez; Sai Merugumala; Alexander P Lin
Journal:  JIMD Rep       Date:  2016-09-28

3.  Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response.

Authors:  Priscila Nicolao Mazzola; Bruno Costa Teixeira; Gabriel Henrique Schirmbeck; Alvaro Reischak-Oliveira; Terry G J Derks; Francjan J van Spronsen; Carlos Severo Dutra-Filho; Ida Vanessa Doederlein Schwartz
Journal:  Mol Genet Metab Rep       Date:  2015-10-22

4.  The PKU & ME study: A qualitative exploration, through co-creative sessions, of attitudes and experience of the disease among adults with phenylketonuria in Italy.

Authors:  Lidia Borghi; Carlotta Moreschi; Alessandra Toscano; Peter Comber; Elena Vegni
Journal:  Mol Genet Metab Rep       Date:  2020-04-02

5.  Large neutral amino acid status in association with P:T ratio and diet in adult and pediatric patients with phenylketonuria.

Authors:  Teresa D Douglas; Anita M Nucci; Ann M Berry; Sarah T Henes; Rani H Singh
Journal:  JIMD Rep       Date:  2019-09-16

6.  The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study.

Authors:  Nicholas M Burgess; Wendy Kelso; Charles B Malpas; Toby Winton-Brown; Timothy Fazio; Julie Panetta; Gerard De Jong; Joanna Neath; Sonny Atherton; Dennis Velakoulis; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2021-01-18       Impact factor: 4.123

7.  Psychological well-being of early and continuously treated phenylketonuria patients.

Authors:  Alena Gerlinde Thiele; Nicole Spieß; Rudolf Ascherl; Maria Arelin; Carmen Rohde; Wieland Kiess; Skadi Beblo
Journal:  JIMD Rep       Date:  2021-02-21

8.  Depression and anxiety among parents of phenylketonuria children.

Authors:  Mehmet Gunduz; Nur Arslan; Ozlem Unal; Sevim Cakar; Pinar Kuyum; Selda F Bulbul
Journal:  Neurosciences (Riyadh)       Date:  2015-10       Impact factor: 0.906

9.  Salivary serotonin does not correlate with central serotonin turnover in adult phenylketonuria (PKU) patients.

Authors:  Joseph Leung; Caroline Selvage; Taryn Bosdet; Jennifer Branov; Annie Rosen-Heath; Carole Bishop; Sandra Sirrs; Gabriella Horvath
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

10.  The Adult Phenylketonuria (PKU) Gut Microbiome.

Authors:  Viviana J Mancilla; Allison E Mann; Yan Zhang; Michael S Allen
Journal:  Microorganisms       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.